Clinical Trials Browser

Phase 3 × Primary Breast Cancer × Anthracyclines × Clear all

NCT01019616 2021-11-29

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Phase 3 Unknown

Primary Breast Cancer